Faeth Therapeutics
FTH
42 hedge funds and large institutions have $37.1M invested in Faeth Therapeutics in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 6 closing their positions.
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
64% more capital invested
Capital invested by funds: $22.7M → $37.1M (+$14.4M)
24% more funds holding
Funds holding: 34 → 42 (+8)
3.94% more ownership
Funds ownership: 7.59% → 11.54% (+3.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.27M |
| 3 |
Millennium Management
New York
|
+$2.35M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.2M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$780K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.46M |
| 2 |
FG
Formula Growth
Montreal,
Quebec, Canada
|
-$976K |
| 3 |
Morgan Stanley
New York
|
-$950K |
| 4 |
MCM
Moore Capital Management
New York
|
-$711K |
| 5 |
ZP
Zimmer Partners
New York
|
-$449K |
FTH Hedge Fund Activity: Q3 2021 in Review
42 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Faeth Therapeutics (FTH) for Q3 2021, worth a combined $37.1M — up 64% from $22.7M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new FTH positions and 6 closed out — a net gain of 8 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $5.8M. The largest seller was Citadel Advisors, cutting an estimated $1.46M.
- 42 institutional investors held Faeth Therapeutics (FTH) as of Q3 2021, up from 34 in Q2 2021.
- Funds reported $37.1M of Faeth Therapeutics stock for Q3 2021, up 64% quarter-over-quarter.
- 14 funds opened new Faeth Therapeutics positions in Q3 2021 and 6 closed out, a net change of +8 holders.
- The largest Faeth Therapeutics buyer in Q3 2021 was BlackRock, an estimated $5.8M added.
- The largest Faeth Therapeutics seller in Q3 2021 was Citadel Advisors, an estimated $1.46M sold.
Based on aggregated 13F filings for Q3 2021.